Bicara Therapeutics Inc (BCAX)
SG&A Expense Growth
11.27%
Quarterly · Period ending:
BCAX SG&A Expense Growth
Latest reported11.27%period ending
Latest reported11.27%period ending
BCAX Quarterly SG&A Growth (QoQ) (0.00% → 11.27%)
Latest values, visible window
High-resolution chart · PNG
BCAX sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 11.2698% | |
| 56.6896% | |
| 5.5967% | |
| 6.662% | |
| -3.1522% | |
| 10.379% | |
| 41.7716% | |
| 21.8726% | |
| 16.9659% | |
| 6.944% | |
| 20.6098% | |
| 45.5618% | |
| 0% | |
| 0% |